Aethlon Medical Stock Performance
| AEMD Stock | USD 0.73 0.01 1.35% |
Aethlon Medical holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -1.62, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Aethlon Medical are expected to decrease by larger amounts. On the other hand, during market turmoil, Aethlon Medical is expected to outperform it. Use Aethlon Medical expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to analyze future returns on Aethlon Medical.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Aethlon Medical are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady primary indicators, Aethlon Medical exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 14.6 M |
Aethlon |
Aethlon Medical Relative Risk vs. Return Landscape
If you would invest 38.00 in Aethlon Medical on November 1, 2024 and sell it today you would earn a total of 35.00 from holding Aethlon Medical or generate 92.11% return on investment over 90 days. Aethlon Medical is currently generating 1.8636% in daily expected returns and assumes 13.7282% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Aethlon, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Aethlon Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aethlon Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aethlon Medical, and traders can use it to determine the average amount a Aethlon Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1358
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | AEMD | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 13.73 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.86 actual daily | 37 63% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average Aethlon Medical is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aethlon Medical by adding it to a well-diversified portfolio.
Aethlon Medical Fundamentals Growth
Aethlon Stock prices reflect investors' perceptions of the future prospects and financial health of Aethlon Medical, and Aethlon Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aethlon Stock performance.
| Return On Equity | -1.05 | ||||
| Return On Asset | -0.5 | ||||
| Current Valuation | 2.64 M | ||||
| Shares Outstanding | 13.96 M | ||||
| Price To Earning | (1.14) X | ||||
| Price To Book | 1.45 X | ||||
| Price To Sales | 2.37 X | ||||
| EBITDA | (11.85 M) | ||||
| Cash And Equivalents | 14.92 M | ||||
| Cash Per Share | 0.65 X | ||||
| Total Debt | 940.32 K | ||||
| Debt To Equity | 0.05 % | ||||
| Book Value Per Share | 2.19 X | ||||
| Cash Flow From Operations | (10.13 M) | ||||
| Earnings Per Share | (2.79) X | ||||
| Total Asset | 8.25 M | ||||
| Retained Earnings | (154.57 M) | ||||
| Current Asset | 817 K | ||||
| Current Liabilities | 1.08 M | ||||
About Aethlon Medical Performance
By analyzing Aethlon Medical's fundamental ratios, stakeholders can gain valuable insights into Aethlon Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Aethlon Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Aethlon Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company was founded in 1999 and is based in San Diego, California. Aethlon Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.Things to note about Aethlon Medical performance evaluation
Checking the ongoing alerts about Aethlon Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aethlon Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aethlon Medical is way too risky over 90 days horizon | |
| Aethlon Medical has some characteristics of a very speculative penny stock | |
| Aethlon Medical appears to be risky and price may revert if volatility continues | |
| Aethlon Medical has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (12.21 M) with profit before overhead, payroll, taxes, and interest of 574.25 K. | |
| Aethlon Medical currently holds about 14.92 M in cash with (10.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.65. |
- Analyzing Aethlon Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aethlon Medical's stock is overvalued or undervalued compared to its peers.
- Examining Aethlon Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aethlon Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aethlon Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aethlon Medical's stock. These opinions can provide insight into Aethlon Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Aethlon Stock analysis
When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |